MannKind Corp. (MNKD)
3.80
-0.15
(-3.80%)
USD |
NASDAQ |
Oct 02, 16:00
3.80
0.00 (0.00%)
After-Hours: 20:00
MannKind Enterprise Value : 1.503B for Oct. 2, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.503B |
| October 01, 2026 | 1.549B |
| September 30, 2026 | 1.534B |
| September 29, 2026 | 1.360B |
| September 28, 2026 | 1.363B |
| September 25, 2026 | 1.360B |
| September 24, 2026 | 1.345B |
| September 23, 2026 | 1.360B |
| September 22, 2026 | 1.407B |
| September 21, 2026 | 1.410B |
| September 18, 2026 | 1.422B |
| September 17, 2026 | 1.435B |
| September 16, 2026 | 1.425B |
| September 15, 2026 | 1.429B |
| September 14, 2026 | 1.487B |
| September 11, 2026 | 1.487B |
| September 10, 2026 | 1.500B |
| September 09, 2026 | 1.546B |
| September 08, 2026 | 1.614B |
| September 04, 2026 | 1.583B |
| September 03, 2026 | 1.552B |
| September 02, 2026 | 1.577B |
| September 01, 2026 | 1.559B |
| August 31, 2026 | 1.568B |
| August 28, 2026 | 1.549B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.583B |
| August 26, 2026 | 1.593B |
| August 25, 2026 | 1.614B |
| August 24, 2026 | 1.587B |
| August 21, 2026 | 1.611B |
| August 20, 2026 | 1.645B |
| August 19, 2026 | 1.687B |
| August 18, 2026 | 1.587B |
| August 17, 2026 | 1.534B |
| August 14, 2026 | 1.518B |
| August 13, 2026 | 1.481B |
| August 12, 2026 | 1.518B |
| August 11, 2026 | 1.515B |
| August 10, 2026 | 1.543B |
| August 07, 2026 | 1.599B |
| August 06, 2026 | 1.531B |
| August 05, 2026 | 1.596B |
| August 04, 2026 | 1.552B |
| August 03, 2026 | 1.503B |
| July 31, 2026 | 1.537B |
| July 30, 2026 | 1.599B |
| July 29, 2026 | 1.518B |
| July 28, 2026 | 1.537B |
| July 27, 2026 | 1.549B |
| July 24, 2026 | 1.605B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| United Therapeutics Corp. | 20.46B |
| ACADIA Pharmaceuticals, Inc. | 2.551B |
| Gilead Sciences, Inc. | 200.90B |
| Vertex Pharmaceuticals, Inc. | 121.99B |
| Ocugen, Inc. | 333.76M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -19.03M |
| Revenue (Quarterly) | 109.37M |
| Total Expenses (Quarterly) | 128.41M |
| EPS Diluted (Quarterly) | -0.0616 |
| Gross Profit Margin (Quarterly) | 69.00% |
| Profit Margin (Quarterly) | -17.40% |
| Earnings Yield | -3.73% |
| Operating Earnings Yield | 1.13% |
| Normalized Earnings Yield | -2.474 |